01 Record
CVE-2020-13183
Reflected Cross Site Scripting in Teradici PCoIP Management Console prior to 20.07 could allow an attacker to take over the user's active session if the user is exposed to a malicious payload.
UnratedPUBLISHEDCNA: Teradici
CNA base scoreUnratedNo CNA CVSS vector
02 Description
Reflected Cross Site Scripting in Teradici PCoIP Management Console prior to 20.07 could allow an attacker to take over the user's active session if the user is exposed to a malicious payload.
03 Exploitation and scoring
- Exploitation
- Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
- SSVC decision
- Not assessed by CISA
- EPSS probability
- 0.64% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Equal to or higher than the score of 50.5% of scored records. A rank, not a probability.
- NVD base score
- 6.1 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- NVD analysis status
- Modified. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
04 Metadata
- Published
- 2020-08-17 20:31Z6 YR AGO
- Last updated
- 2024-08-04 12:11Z2 YR AGO
- Reserved
- 2020-05-19
- Assigning CNA
- Teradici
- Record state
- PUBLISHED
- Severity
- Not rated by the issuing CNA
- CNA CVSS vector
- Not published by the issuing CNA
- Weaknesses
- CWE-79Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')Base
- Data version
- 5.1
- Document digest
- 8ce57934eaa12d0a893620173035314d8dc45db81d28653c0c39689574f6073e
05 Affected products
VendorProductVersionsPlatforms
06 References
- advisory.teradici.comhttps://advisory.teradici.com/security-advisories/63/